Janneke M Brussee

12PUBLICATIONS
14CO-AUTHORS
Metabolic medicinePharmacogenomicsEpidemiological methodsInfant and child healthNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 20, 2026
Population Pharmacokinetic Modeling for the Iminosugar Lucerastat Supports Dose Adaptation in Patients With Fabry Disease and Moderate to Severe Renal Function Impairment.

|Sep 12, 2025
Clinical Evaluation of QTc Interval Prolongation With the Dual Endothelin Receptor Antagonist Aprocitentan.

P N Sidharta, J M Brussee, A Schultz

|Feb 09, 2024
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension.

Janneke M Brussee, Patricia N Sidharta, Jasper Dingemanse

|Oct 30, 2022
Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist.

Andreas Krause, Dominik Lott, Janneke M Brussee

|Feb 13, 2022
Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults.

Daniela Hofmann, Janneke M Brussee, Jessica D Schulz

|Mar 06, 2021
Insufficient Stability of Clavulanic Acid in Widely Used Child-Appropriate Formulations.

Ines Mack, Mike Sharland, Janneke M Brussee

Pageof 2

Frequent Collaborators

3 joint publications

Jennifer Keiser

3 joint publications

Andreas Krause

3 joint publications

Jasper Dingemanse

2 joint publications

Patricia N Sidharta